May 9, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the American College of Cardiology (ACC), a first edition of a framework for the CADScor System. The framework offers a workflow for the CADScor System as a diagnostic aid in patients with stable chest pain.
New onset stable chest pain is a common problem in the United States. Distinguishing between serious and benign chest pain is imperative to appropriately stratify patients to determine their best course of care. Risk stratification can be challenging, especially in care settings with limited cardiology resources, lack of access to diagnostic testing, or high patient volumes that result in extended wait times for assessment.
The ACC recognizes the challenges of risk stratification in patients with chest pain and collaborated with Acarix to assess the utility and role of the CADScor System. Through this collaboration, a framework has been developed for the proposed use of the CADScor System as an early diagnostic aid in the assessment of chest pain.
"As novel diagnostic technologies emerge, the ACC, through its Innovation Program, is focused on collaborating with companies to develop workflows and usability frameworks early in development to facilitate implementation of these technologies in our healthcare systems.” stated Ami Bhatt, MD, FACC, ACC Chief Innovation Officer.
"We appreciate the opportunity to collaborate with the ACC on the development of the CADScor System framework," stated Helen Ljungdahl Round, Acarix President & CEO. “Together, we are paving the way for a new, innovative diagnostic solution and providing a rapid response, powered by our unique acoustic and AI-based technology."
For more information: www.acarix.com
Related Content:
Acarix Accelerates US Commercialization into 30 Additional States
Study published in Heart strengthens diagnostic value of Acarix CADScor System
Acarix Presents CADScor System at ESC 2018
July 31, 2024 
